当前位置:首页 - 行情中心 - 海创药业-U(688302) - 财务分析 - 现金流量表

海创药业-U

(688302)

  

流通市值:30.34亿  总市值:30.34亿
流通股本:9901.56万   总股本:9901.56万

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金46,239,239.4827,001,460.0525,743,692.3519,840,149.57
  收到其他与经营活动有关的现金24,782,504.9521,577,545.5645,187,361.1134,656,225.62
  经营活动现金流入小计71,021,744.4348,579,005.6170,931,053.4654,496,375.19
  购买商品、接受劳务支付的现金4,322,779.032,133,748.733,914,602.353,111,340.43
  支付给职工以及为职工支付的现金46,781,898.8527,528,085.473,048,754.957,199,710.18
  支付的各项税费613,146.5952,873.741,115,591.57588,066.12
  支付其他与经营活动有关的现金65,697,997.7229,992,283.27101,730,393.1273,306,230.36
  经营活动现金流出小计117,415,822.1959,706,991.14179,809,341.94134,205,347.09
  经营活动产生的现金流量净额-46,394,077.76-11,127,985.53-108,878,288.48-79,708,971.9
二、投资活动产生的现金流量:
  收回投资收到的现金960,000,000540,000,0002,485,050,0001,870,050,000
  取得投资收益收到的现金3,462,016.841,411,298.648,441,969.135,940,964.77
  处置固定资产、无形资产和其他长期资产收回的现金净额718718147.38147.38
  收到的其他与投资活动有关的现金--34,740,340.3241,397,341.63
  投资活动现金流入小计963,462,734.84541,412,016.642,528,232,456.831,917,388,453.78
  购建固定资产、无形资产和其他长期资产支付的现金14,626,555.818,234,114.7982,886,135.8157,314,600.67
  投资支付的现金1,020,000,000520,000,0002,585,050,0002,070,050,000
  支付其他与投资活动有关的现金---8,698,614.4
  投资活动现金流出小计1,034,626,555.81528,234,114.792,667,936,135.812,136,063,215.07
  投资活动产生的现金流量净额-71,163,820.9713,177,901.85-139,703,678.98-218,674,761.29
三、筹资活动产生的现金流量:
  取得借款收到的现金--100,000,000100,000,000
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--100,000,000100,000,000
  分配股利、利润或偿付利息支付的现金1,299,277.78642,5001,242,166.67592,527.78
  支付其他与筹资活动有关的现金2,038,895.88965,131.363,517,163.032,763,637.47
  筹资活动现金流出小计3,338,173.661,607,631.364,759,329.73,356,165.25
  筹资活动产生的现金流量净额-3,338,173.66-1,607,631.3695,240,670.396,643,834.75
四、汇率变动对现金及现金等价物的影响-3,480,461.43-1,698,760.99-2,294,393.72-1,084,227.63
五、现金及现金等价物净增加额-124,376,533.82-1,256,476.03-155,635,690.88-202,824,126.07
  加:期初现金及现金等价物余额437,590,365.61437,590,365.61593,226,056.49593,226,056.49
  期末现金及现金等价物余额313,213,831.79436,333,889.58437,590,365.61390,401,930.42
补充资料:
  净利润-56,218,129.78--137,252,611.25-
  固定资产和投资性房地产折旧3,541,047.72-3,523,342.55-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧3,541,047.72-3,523,342.55-
  无形资产摊销--695,059.88-
  处置固定资产、无形资产和其他长期资产的损失7,243.31---
  公允价值变动损失-3,608,863.32--10,167,088.15-
  财务费用3,313,376.21--451,501.07-
  投资损失-1,939,220.22--5,184,084.25-
  存货的减少-12,449,205.81--2,840,989.8-
  经营性应收项目的减少-10,700,053.31-1,349,150.68-
  经营性应付项目的增加29,328,611.64-28,994,973.13-
  其他269,710.6-8,683,522.9-
  现金的期末余额313,213,831.79-437,590,365.61-
  减:现金的期初余额437,590,365.61-593,226,056.49-
  现金及现金等价物的净增加额-124,376,533.82--155,635,690.88-
公告日期2026-08-272026-04-252026-04-252025-10-31
审计意见(境内)标准无保留意见
TOP↑